These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35398970)

  • 1. In vitro virucidal activity of mouthwashes on SARS-CoV-2.
    Buonavoglia A; Lanave G; Marchi S; Lorusso P; Montomoli E; Martella V; Camero M; Prati C; Trombetta CM
    Oral Dis; 2022 Nov; 28 Suppl 2():2509-2515. PubMed ID: 35398970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virucidal activity in vitro of mouthwashes against a feline coronavirus type II.
    Buonavoglia A; Camero M; Lanave G; Catella C; Trombetta CM; Gandolfi MG; Palazzo G; Martella V; Prati C
    Oral Dis; 2022 Nov; 28 Suppl 2(Suppl 2):2492-2499. PubMed ID: 34739171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
    Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
    J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
    Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
    Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
    Muñoz-Basagoiti J; Perez-Zsolt D; León R; Blanc V; Raïch-Regué D; Cano-Sarabia M; Trinité B; Pradenas E; Blanco J; Gispert J; Clotet B; Izquierdo-Useros N
    J Dent Res; 2021 Oct; 100(11):1265-1272. PubMed ID: 34282982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
    Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
    J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
    Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
    BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of various gargle formulations and salt water against SARS-CoV-2.
    Tiong V; Hassandarvish P; Bakar SA; Mohamed NA; Wan Sulaiman WS; Baharom N; Abdul Samad FN; Isahak I
    Sci Rep; 2021 Oct; 11(1):20502. PubMed ID: 34654867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virucidal Properties of Molecular Iodine Oral Rinse Against SARS-CoV-2.
    Teagle V; Clem DS; Yoon T
    Compend Contin Educ Dent; 2022 Feb; 43(2):e13-e16. PubMed ID: 35148480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could certain mouthwashes reduce transmissibility of COVID-19?
    Elmahgoub F; Coll Y
    Evid Based Dent; 2021 Jan; 22(2):82-83. PubMed ID: 34172918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virucidal efficacy of chlorhexidine: a systematic review.
    Fernandez MDS; Guedes MIF; Langa GPJ; Rösing CK; Cavagni J; Muniz FWMG
    Odontology; 2022 Apr; 110(2):376-392. PubMed ID: 34637092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.
    Alemany A; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Ouchi D; Laporte-Villar C; Baro B; Henríquez N; Prat N; Gianinetto MO; Gutiérrez MV; Sánchez-Paniagua MG; Henríquez NL; Vicente JM; Ara J; Rodriguez-Arias MA; Puig J; Blanco I; Lopez CC; Hernández Á; Bordoy AE; Redondo CE; Soler VG; Giménez M; Blanc V; León R; Gispert J; ; Clotet B; Izquierdo-Useros N; Mitjà O
    J Dent Res; 2022 Nov; 101(12):1450-1456. PubMed ID: 35727681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
    Chen MH; Chang PC
    J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1.
    Riveira-Muñoz E; Garcia-Vidal E; Bañó-Polo M; León R; Blanc V; Clotet B; Ballana E
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.
    Steinhauer K; Meister TL; Todt D; Krawczyk A; Paßvogel L; Becker B; Paulmann D; Bischoff B; Pfaender S; Brill FHH; Steinmann E
    J Hosp Infect; 2021 May; 111():180-183. PubMed ID: 33582201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virucidal Activities of Acidic Electrolyzed Water Solutions with Different pH Values against Multiple Strains of SARS-CoV-2.
    Takeda Y; Nikaido M; Jamsransuren D; Matsuda S; Ogawa H
    Appl Environ Microbiol; 2023 Jan; 89(1):e0169922. PubMed ID: 36511659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2.
    Takeda R; Sawa H; Sasaki M; Orba Y; Maishi N; Tsumita T; Ushijima N; Hida Y; Sano H; Kitagawa Y; Hida K
    Sci Rep; 2022 Aug; 12(1):14050. PubMed ID: 35982118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel, entirely herbal-based mouthwash effective against common oral bacteria and SARS-CoV-2.
    Bencze B; Temesfői V; Das S; Papp H; Kaltenecker P; Kuczmog A; Jakab F; Kocsis B; Kőszegi T
    BMC Complement Med Ther; 2023 May; 23(1):138. PubMed ID: 37127611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.